Floatz logo

(1-743)-(1638-2332)-BLOOD-COAGULATION FACTOR VIII (SYNTHETIC HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (SYNTHETIC HUMAN FC DOMAIN FRAGMENT), (1444-6'),(1447-9')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (SYNTHETIC HUMAN FC DOMAIN FRAGMENT)

Haemophilia B

Swedish Orphan Biovitrumprotein_peptideDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

33 Active assets in the Haemophilia B cohort.

Asset / SponsorPhaseRating
Eptacog Alfa
AryoGen Pharmed Co.
Phase 4A
Factor Ix
CSL Behring
Phase 4A
Benefix
Pfizer
Phase 4A
Nonacog Beta Pegol
Novo Nordisk A/S
Phase 3A
Factor Ix
CSL Behring
Phase 4BBB

View all 50 →

Same molecule, other indications

(1-743)-(1638-2332)-BLOOD-COAGULATION FACTOR VIII (SYNTHETIC HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (SYNTHETIC HUMAN FC DOMAIN FRAGMENT), (1444-6'),(1447-9')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (SYNTHETIC HUMAN FC DOMAIN FRAGMENT) is also rated in:

hemophilia ADormant
BB
Indicative ·
66 / 100
View asset →
hemophilia ADormant
B
Indicative ·
62 / 100
View asset →
severe hemophilia ADormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →